Cargando…
Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women
OBJECTIVE: To examine the anthropometric, and metabolic connections of 17-hydroxypregnenolone in the normo- and hyperandrogenemic polycystic ovary syndrome phenotypes. MATERIALS AND METHODS: This cohort study was conducted at the Julio Muller University Hospital, Cuiabá, Brazil, between January 2014...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592777/ https://www.ncbi.nlm.nih.gov/pubmed/28784626 http://dx.doi.org/10.1530/EC-17-0151 |
_version_ | 1783262940052324352 |
---|---|
author | de Medeiros, Sebastião Freitas Ormond, Cinthia Marenza de Medeiros, Matheus Antônio Souto de Souza Santos, Nayara Banhara, Camila Regis Yamamoto, Márcia Marly Winck |
author_facet | de Medeiros, Sebastião Freitas Ormond, Cinthia Marenza de Medeiros, Matheus Antônio Souto de Souza Santos, Nayara Banhara, Camila Regis Yamamoto, Márcia Marly Winck |
author_sort | de Medeiros, Sebastião Freitas |
collection | PubMed |
description | OBJECTIVE: To examine the anthropometric, and metabolic connections of 17-hydroxypregnenolone in the normo- and hyperandrogenemic polycystic ovary syndrome phenotypes. MATERIALS AND METHODS: This cohort study was conducted at the Julio Muller University Hospital, Cuiabá, Brazil, between January 2014 and July 2016, and 91 normal cycling healthy women, 46 normoandrogenemic and 147 hyperandrogenemic, patients with polycystic ovary syndrome (PCOS) were enrolled according to the Rotterdam criteria. Several anthropometric, biochemical and hormonal parameters were properly verified and correlated with 17-hydroxypregnenolone (17-OHPE) concentrations. RESULTS: 17-OHPE was higher in hyperandrogenemic PCOS than in normoandrogenemic PCOS and in control groups (P = 0.032 and P < 0.001, respectively). In healthy controls, 17-OHPE was positively associated with glucose, free estrogen index, DHEAS and negatively associated with compounds S. In normoandrogenemic PCOS patients, 17-OHPE presented positive correlations with VAI, LAP, cortisol, insulin and HOMA-IR. In the hyperandrogenemic group, 17-OHPE presented significant negative correlations with most anthropometric parameters, HOMA-IR, HOMA %B, estradiol, free estrogen index (FEI), C-peptide, and TG levels and positive correlations with HOMA-S and high-density lipoprotein cholesterol (HDL-C), sex-hormone binding globulin (SHBG), androstenedione (A4) and dehydroepiandrosterone (DHEA). Regarding hyperandrogenemic PCOS, and using a stepwise multiple regression, only HOMA-S and WHR were retained in the model (R(2) = 0.294, P < 0.001). CONCLUSION: 17-OHPE exhibited different relationships with anthropometric, and biochemical parameters in PCOS patients, depending on the androgen levels. In PCOS subjects with high androgen concentrations, 17-OHPE was negatively associated with most anthropometric parameters, particularly with those used as markers of adipose tissue dysfunction and frequently employed as predictors of cardiovascular disease risk; otherwise, 17-OHPE was positively associated with HDL-C and HOMA-S in this patients. Future studies are required to evaluate the clinical implications of these novel findings. |
format | Online Article Text |
id | pubmed-5592777 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Bioscientifica Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-55927772017-09-18 Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women de Medeiros, Sebastião Freitas Ormond, Cinthia Marenza de Medeiros, Matheus Antônio Souto de Souza Santos, Nayara Banhara, Camila Regis Yamamoto, Márcia Marly Winck Endocr Connect Research OBJECTIVE: To examine the anthropometric, and metabolic connections of 17-hydroxypregnenolone in the normo- and hyperandrogenemic polycystic ovary syndrome phenotypes. MATERIALS AND METHODS: This cohort study was conducted at the Julio Muller University Hospital, Cuiabá, Brazil, between January 2014 and July 2016, and 91 normal cycling healthy women, 46 normoandrogenemic and 147 hyperandrogenemic, patients with polycystic ovary syndrome (PCOS) were enrolled according to the Rotterdam criteria. Several anthropometric, biochemical and hormonal parameters were properly verified and correlated with 17-hydroxypregnenolone (17-OHPE) concentrations. RESULTS: 17-OHPE was higher in hyperandrogenemic PCOS than in normoandrogenemic PCOS and in control groups (P = 0.032 and P < 0.001, respectively). In healthy controls, 17-OHPE was positively associated with glucose, free estrogen index, DHEAS and negatively associated with compounds S. In normoandrogenemic PCOS patients, 17-OHPE presented positive correlations with VAI, LAP, cortisol, insulin and HOMA-IR. In the hyperandrogenemic group, 17-OHPE presented significant negative correlations with most anthropometric parameters, HOMA-IR, HOMA %B, estradiol, free estrogen index (FEI), C-peptide, and TG levels and positive correlations with HOMA-S and high-density lipoprotein cholesterol (HDL-C), sex-hormone binding globulin (SHBG), androstenedione (A4) and dehydroepiandrosterone (DHEA). Regarding hyperandrogenemic PCOS, and using a stepwise multiple regression, only HOMA-S and WHR were retained in the model (R(2) = 0.294, P < 0.001). CONCLUSION: 17-OHPE exhibited different relationships with anthropometric, and biochemical parameters in PCOS patients, depending on the androgen levels. In PCOS subjects with high androgen concentrations, 17-OHPE was negatively associated with most anthropometric parameters, particularly with those used as markers of adipose tissue dysfunction and frequently employed as predictors of cardiovascular disease risk; otherwise, 17-OHPE was positively associated with HDL-C and HOMA-S in this patients. Future studies are required to evaluate the clinical implications of these novel findings. Bioscientifica Ltd 2017-08-07 /pmc/articles/PMC5592777/ /pubmed/28784626 http://dx.doi.org/10.1530/EC-17-0151 Text en © 2017 The authors http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research de Medeiros, Sebastião Freitas Ormond, Cinthia Marenza de Medeiros, Matheus Antônio Souto de Souza Santos, Nayara Banhara, Camila Regis Yamamoto, Márcia Marly Winck Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women |
title | Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women |
title_full | Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women |
title_fullStr | Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women |
title_full_unstemmed | Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women |
title_short | Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women |
title_sort | metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592777/ https://www.ncbi.nlm.nih.gov/pubmed/28784626 http://dx.doi.org/10.1530/EC-17-0151 |
work_keys_str_mv | AT demedeirossebastiaofreitas metabolicandendocrineconnectionsof17hydroxypregnenoloneinpolycysticovarysyndromewomen AT ormondcinthiamarenza metabolicandendocrineconnectionsof17hydroxypregnenoloneinpolycysticovarysyndromewomen AT demedeirosmatheusantoniosouto metabolicandendocrineconnectionsof17hydroxypregnenoloneinpolycysticovarysyndromewomen AT desouzasantosnayara metabolicandendocrineconnectionsof17hydroxypregnenoloneinpolycysticovarysyndromewomen AT banharacamilaregis metabolicandendocrineconnectionsof17hydroxypregnenoloneinpolycysticovarysyndromewomen AT yamamotomarciamarlywinck metabolicandendocrineconnectionsof17hydroxypregnenoloneinpolycysticovarysyndromewomen |